Assessment of Niacinamide Cosmetic Product Efficacy in Model of Irritant Contact Dermatitis
NCT06331390 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2024-03-26
Summary
Testing the effectiveness and safety of cosmetics with niacinamide in irritant contact dermatitis: A Randomised, Controlled Trial will be conducted at USSM. Healthy volunteers will be included (at least 25) and test sites are forearms. Sodium lauryl sulphate will be used to induce contact dermatitis and participants will be measured for 7 days
Conditions
- Contact Dermatitis
Interventions
- OTHER
-
niacinamide cosmetic product
immortella skincare product
- OTHER
-
placebo
nothing
Sponsors & Collaborators
-
University of Split, School of Medicine
lead OTHER
Principal Investigators
-
JOSIPA BUKIĆ · USSM
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-30
- Primary Completion
- 2024-06-30
- Completion
- 2024-07-31
Countries
- Croatia
Study Locations
More Related Trials
-
To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products
NCT04007159 ·Status: COMPLETED ·Phase: NA
-
Prospective Single Center Randomized Double Blind Controlled Tolerability Trial of Six Hair Cleansing Conditioners
NCT03483025 ·Status: COMPLETED ·Phase: NA
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT02441608 ·Status: COMPLETED ·Phase: NA
-
Dermatological Evaluation of Topical Compatibility, Primary Skin Irritability, Accumulated Skin Irritability, and Dermal Sensitisation
NCT02419248 ·Status: COMPLETED
-
Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area
NCT03464890 ·Status: COMPLETED ·Phase: NA
-
NI-0801 in Allergic Contact Dermatitis
NCT01244607 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin
NCT03640832 ·Status: COMPLETED ·Phase: NA
-
To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test
NCT03233009 ·Status: COMPLETED ·Phase: NA
-
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466 ·Status: COMPLETED ·Phase: NA
-
Assessment of Skin Barrier Disruption Due to Daily Use of Cleaning Products and Hand Disinfectants
NCT06269315 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Skin Irritation Test of Ten Products
NCT05245383 ·Status: UNKNOWN ·Phase: NA
-
Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test
NCT01892657 ·Status: COMPLETED ·Phase: PHASE4
-
Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis
NCT00196430 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous
NCT01429701 ·Status: COMPLETED ·Phase: PHASE3
-
Cumulative Irritation Test of PAC-14028 in Healthy Volunteers
NCT01638117 ·Status: COMPLETED ·Phase: PHASE1
-
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser
NCT01888887 ·Status: COMPLETED ·Phase: NA
-
This Was a Clinical Study Investigating the Moisturization and Desquamation Effect of AmLactin® Rapid Relief Restoring Lotion + Ceramides on Dry Skin in Healthy Female Volunteers. AmLactin® Rapid Relief is an Over-the-counter Cosmetic
NCT04085809 ·Status: COMPLETED ·Phase: NA
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Safety Study of New Sinecort Formulation Versus Positive Control
NCT00885937 ·Status: COMPLETED ·Phase: PHASE1
-
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization
NCT04248556 ·Status: COMPLETED ·Phase: NA
-
Topical Safety Study of Topical Diltiazem Hydrochloride
NCT01816529 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity
NCT03015103 ·Status: UNKNOWN ·Phase: NA
-
Epidemiology and Co-Reactivity of Novel Surfactant Allergens
NCT02534441 ·Status: COMPLETED ·Phase: NA
-
The Role of Bacterial Toxins in Human Skin Disease
NCT02910791 ·Status: UNKNOWN
-
A Study to Evaluate the Skin Irritation Potential of PBI-100 Topical Cream in Healthy Participants
NCT04882631 ·Status: COMPLETED ·Phase: PHASE1